Skip to main content
. 2020 Jan 28;11(4):462–479. doi: 10.18632/oncotarget.27468

Table 1. Percent of SNPs displaying ASE in 233 TCGA patients.

Pattern % Total SNPs % All COSMIC % TSG % Oncogene % Fusion
BRCA 1 7.3 7.6 7.3 7.0 8.3
2 0.4 0.8 0.3 0.4 1.4
3 0.1 0.2 0.0 0.0 0.3
4 3.8 4.1 3.7 3.4 4.8
5 2.6 2.5 2.8 2.2 2.7
6 0.5 0.5 0.8 0.4 0.4
No ASE 85.2 84.4 85.1 86.6 82.1
HNSC 1 8.7 9.7 10.5 10.1 8.3
2 0.4 0.4 0.0 0.0 0.9
3 0.2 0.3 0.0 0.0 0.6
4 4.6 4.5 3.7 4.2 4.7
5 2.1 1.7 1.3 1.2 2.0
6 0.7 1.0 0.5 0.9 1.0
No ASE 83.4 82.5 83.9 83.5 82.4
LUAD 1 9.7 10.7 9.2 9.8 12.0
2 0.3 1.0 0.1 0.0 2.0
3 0.2 1.0 0.0 0.0 1.9
4 5.4 6.8 7.0 6.5 6.9
5 1.9 2.3 2.2 1.6 2.7
6 0.7 0.8 1.1 0.6 0.9
No ASE 81.7 77.4 80.4 81.5 73.5
THCA 1 2.1 2.3 2.3 1.7 2.6
2 0.2 0.5 0.0 0.1 1.0
3 0.0 0.0 0.0 0.0 0.0
4 0.5 0.8 0.5 0.4 1.1
5 1.6 1.9 1.3 2.0 2.1
6 0.1 0.0 0.0 0.0 0.0
No ASE 95.5 94.5 95.9 95.8 93.2